Data from Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer
Linjie Zhao,Gaili Ji,Xiaobing Le,Chenlu Wang,Xu Liu,Ming Feng,Yaguang Zhang,Huiliang Yang,Yi Xuan,Yong Yang,Lei Luo,Qilian Yang,Wayne Bond Lau,Bonnie Lau,Yi Chen,Xia Deng,Shuhuai Yao,Tao Yi,Xiujian Zhao,Yuquan Wei,Shengtao Zhou
DOI: https://doi.org/10.1158/0008-5472.c.6509649.v1
2023-01-01
Abstract:Abstract The majority of patients with epithelial ovarian cancer are diagnosed at a late stage when the peritoneal metastases exist; however, there is little knowledge of the metastatic process in this disease setting. In this study, we report the identification of the long noncoding RNA LINC00092 as a nodal driver of metastatic progression mediated by cancer-associated fibroblasts (CAF). Prometastatic properties of CAFs in vitro and in vivo were found to associate with elevated expression of the chemokine CXCL14. In clinical specimens, elevated levels of CXCL14 in CAFs also correlated with poor prognosis. Notably, CXCL14-high CAFs mediated upregulation of LINC00092 in ovarian cancer cells, the levels of which also correlated with poor prognosis in patients. Mechanistic studies showed that LINC00092 bound a glycolytic enzyme, the fructose-2,6-biphosphatase PFKFB2, thereby promoting metastasis by altering glycolysis and sustaining the local supportive function of CAFs. Overall, our study uncovered a positive feedback loop in the metabolism of CXCL14-positive CAFs and ovarian cancer cells that is critical for metastatic progression. Cancer Res; 77(6); 1369–82. ©2017 AACR.